GKOS
Glaukos Corporation
59.77
USD
This page is just a preview of the data found in TrendSpider’s full version
Glaukos Corporation stock is down -10.55% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 8 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs. 75% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 01 Nov 19:47 | 19 Jan, 2024 | 70.00 | 77 | ||
| 17 Nov 20:54 | 19 Jan, 2024 | 62.50 | 7 | ||
| 21 Nov 19:54 | 19 Jan, 2024 | 62.50 | 144 | ||
| 22 Nov 14:49 | 19 Jan, 2024 | 67.50 | 268 | ||
| 27 Nov 19:29 | 19 Jan, 2024 | 62.50 | 1033 | ||
| 27 Nov 20:43 | 19 Jan, 2024 | 67.50 | 414 | ||
| 28 Nov 18:44 | 19 Jan, 2024 | 52.50 | 40 | ||
| 28 Nov 19:21 | 19 Jan, 2024 | 62.50 | 1394 | ||
| 28 Nov 20:36 | 19 Jan, 2024 | 62.50 | 1394 | ||
| 28 Nov 20:44 | 19 Jan, 2024 | 52.50 | 40 |
Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally.
